Reply to: "Correspondence on the <BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update>"

Maria Reig¹, Jordi Bruix²

Affiliations

¹ BCLC group, Liver Unit, Digestive Disease Institute, Hospital Clínic, IDIBAPS CIBEREHD, University of Barcelona, Barcelona, Spain. Electronic address: mreig1@clinic.cat.
² BCLC group, Liver Unit, Digestive Disease Institute, Hospital Clínic, IDIBAPS CIBEREHD, University of Barcelona, Barcelona, Spain. Electronic address: jbruix@clinic.cat.

PMID: 35283212
DOI: 10.1016/j.jhep.2022.02.026

Comment

Reply to: "Correspondence on the <BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update>"

Maria Reig et al. J Hepatol. 2022 May.

. 2022 May;76(5):1240-1241.

doi: 10.1016/j.jhep.2022.02.026. Epub 2022 Mar 11.

Authors

Maria Reig¹, Jordi Bruix²

Affiliations

¹ BCLC group, Liver Unit, Digestive Disease Institute, Hospital Clínic, IDIBAPS CIBEREHD, University of Barcelona, Barcelona, Spain. Electronic address: mreig1@clinic.cat.
² BCLC group, Liver Unit, Digestive Disease Institute, Hospital Clínic, IDIBAPS CIBEREHD, University of Barcelona, Barcelona, Spain. Electronic address: jbruix@clinic.cat.

PMID: 35283212
DOI: 10.1016/j.jhep.2022.02.026

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment on

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Fuster J, Ayuso C, Bruix J. Reig M, et al. J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19. J Hepatol. 2022. PMID: 34801630 Free PMC article. Review.
Liver dysfunction in Barcelona Clinic Liver Cancer-2022 update: Clear as day or still in fog?
Elhence A, Shalimar. Elhence A, et al. J Hepatol. 2022 May;76(5):1236-1237. doi: 10.1016/j.jhep.2021.12.016. Epub 2021 Dec 23. J Hepatol. 2022. PMID: 34954248 No abstract available.
BCLC 2022 update: Important advances, but missing external beam radiotherapy.
Hallemeier CL, Apisarnthanarax S, Dawson LA. Hallemeier CL, et al. J Hepatol. 2022 May;76(5):1237-1239. doi: 10.1016/j.jhep.2021.12.029. Epub 2022 Jan 3. J Hepatol. 2022. PMID: 34990748 No abstract available.
The updated BCLC staging system needs further refinement: A surgeon's perspective.
Xu X, Lau WY, Yang T. Xu X, et al. J Hepatol. 2022 May;76(5):1239-1240. doi: 10.1016/j.jhep.2022.01.002. Epub 2022 Jan 20. J Hepatol. 2022. PMID: 35066088 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to: "Correspondence on the <BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update>"

Affiliations

Reply to: "Correspondence on the <BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update>"

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical